期刊文献+

RGD肽对肺癌A549细胞增殖侵袭能力的影响及其机制研究

Effect of RGD Peptide on the Proliferation and Invasion of Lung Cancer A549 and its Mechanism
原文传递
导出
摘要 目的:研究RGD肽对肺癌A549细胞增殖凋亡及侵袭迁移的影响,并探讨其作用机制。方法:不同浓度RGD肽处理肺癌A549细胞后,MTT检测肺癌细胞的增殖能力,流式细胞仪检测肺癌细胞凋亡及周期分布,Transwell检测其迁移及侵袭能力的变化,Western blot检测RGD肽对肺癌A549细胞MMP2、MMP9的表达水平影响。结果:当RGD肽浓度增加至50 mg/L时,肺癌A549细胞增殖明显受到抑制,且这种抑制作用呈剂量依赖关系;RGD肽组A549细胞G0/G1期细胞比例增高,细胞凋亡率由(6.1±0.1)%增至(15.2±0.5)%;在迁移和侵袭试验中,RGD肽组A549细胞的穿膜细胞数分别由123±10和43±10降至45±5和18±5;RGD肽组A549细胞MMP2、MMP9表达水平显著降低。结论:RGD肽对肺癌A549细胞的增殖有明显抑制作用,并促进其凋亡,可能与RGD肽改变其周期分布有关,RGD肽可明显抑制A549细胞的迁移及侵袭,可能与其下调MMP2、MMP9的表达相关。 Objective: To investigate the effect ofRGD peptide on the proliferation, apoptosis, migration and invasion of the lung cancer A549 and explore its mechanism. Methods: MTT was performed to reveal the inhibitory effect on cell proliferation after different doses of RGD peptide were added to the A549 cell. Flow cytometry was used to determine the apoptosis and cell cycle of A549 cell. Transwell was performed to identify the migration and invasion of A549 cell. The expression level of MMP2 and MMP9 was measured by Western blot. Results: When the concentration of RGD peptide increased to 50 mg/L, there was a dose-dependent inhibition of cell proliferation of A549. In RGD peptide group, the rate of GO/G1 increased and apoptosis rate of A549 increased from (6.1 ± 0.1) % to (15.2± 0.5) %. In RGD peptide group, the number of migrated and invaded cells decreased from 123± 10, 43± 10 to 45±5, 18±5, respectively. Moreover, RGD peptide down-regulated the expression of MMP2 and MMP9. Conclusion: RGD peptide can inhibit the proliferation and promote the apoptosis of A549 cell line through changing cell cycle, suppressing the migration and invasion by down-regulating the MMP2 and MMP9 expression.
出处 《现代生物医学进展》 CAS 2016年第14期2637-2640,2758,共5页 Progress in Modern Biomedicine
关键词 RGD肽 肺癌 增殖 凋亡 侵袭 迁移 RGD peptide Lung cancer Proliferation Apoptosis Invasion Migration
  • 相关文献

参考文献20

  • 1Greenlee R T, Murray T, Bolden S, et al. Cancer statistics, 2000[J]. CA Cancer J Clin, 2000, 50(1): 7-33.
  • 2Rosell R. Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer [J]. EBioMedicine, 2014, 1 (2-3): 103-104.
  • 3Yang Y, Ji S, Liu S. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides[J]. Bioconjugate chemistry, 2014, 25(9): 1720-1729.
  • 4Chang R, Sun L, Webster T J. Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres [J]. International journal of nanomedicine, 2015, 10:3351-3365.
  • 5[ Feng M X, Ma M Z, Fu Y, et al. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation[J]. Molecular cancer, 2014, 13:226.
  • 6Yang Y, Xu H, Shen J, et al. RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells[J]. Cell death & disease, 2015, 6: e 1760.
  • 7Hu Z, Arrowsmith R L, Tyson J A, et al. A fluorescent Arg-Gly-Asp (RGD) peptide-naphthalenediimide (NDI) conjugate for imaging integrin alpha(v)beta(3) in vitro[J]. Chemical communications, 2015, 51 (32): 6901-6904.
  • 8Lee C Y, Shim H S, Lee S, et al. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer[J]. Journal ofcardiothoracic surgery, 2015, 10:44.
  • 9Wang R, Ke Z F, Wang F, el al. GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9 [J]. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, 35(3): 969-982.
  • 10El-badrawy M K, Yousef A M, Shaalan D, ct al. Matrix metalloproteinasc-9 expression in lung cancer patients and its relation to serum romp-9 activity, pathologic type, and prognosis [J]. Journal ofbronchology & interventional pulmonology, 2014, 21(4): 327-334.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部